Lipoprotein Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Lipoprotein stocks.

Lipoprotein Stocks Recent News

Date Stock Title
Nov 21 ESPR Esperion to Participate in Upcoming Piper Sandler 36th Annual Healthcare Conference
Nov 21 NAMS NewAmsterdam Pharma Reports Promising Phase 3 Trial Results
Nov 21 QURE uniQure Announces Dosing of First Patient in GenTLE Phase I/IIa Clinical Trial of AMT-260 for the Treatment of Refractory Mesial Temporal Lobe Epilepsy
Nov 20 NAMS NewAmsterdam Dives — And Sacrifices A Cup Base — Despite A Winning Cholesterol Study
Nov 20 NAMS NewAmsterdam Pharma says late-stage trial for cholesterol drug succeeded
Nov 20 NAMS NewAmsterdam Pharma Announces Positive Topline Data from Pivotal Phase 3 TANDEM Clinical Trial Evaluating the Fixed-Dose Combination of Obicetrapib 10 mg and Ezetimibe 10 mg in Patients with ASCVD or ASCVD Risk Factors and/or HeFH
Nov 19 REGN Regeneron Pharmaceuticals, Inc. (REGN): Among the Best Genomics Stocks to Buy Right Now
Nov 19 REGN Regeneron Pharmaceuticals, Inc. (REGN) Jefferies London Healthcare Conference (Transcript)
Nov 19 REGN Regeneron: The Biotech Stock To Buy Now
Nov 19 REGN Here’s Why Regeneron Pharmaceuticals (REGN) Declined in Q3
Nov 19 AMRN After Plunging -19.13% in 4 Weeks, Here's Why the Trend Might Reverse for Amarin (AMRN)
Nov 19 AMRN Top 3 Health Care Stocks You'll Regret Missing In Q4
Nov 18 NAMS NewAmsterdam Pharma Presents Additional Data from Pivotal Phase 3 BROOKLYN Clinical Trial Evaluating Obicetrapib in Patients with Heterozygous Familial Hypercholesterolemia at AHA Scientific Sessions 2024
Nov 18 REGN FDA Accepts SNY and REGN's Dupixent Re-Submitted sBLA for Urticaria
Nov 18 RGNX Regenxbio surges 10% as it launches pivotal phase of muscular dystrophy asset trial
Nov 18 ESPR Esperion Highlights New Exploratory Data from CLEAR Outcomes Trial Highlighting Value of NEXLETOL® (bempedoic acid) in Oral Featured Science Session and Multiple Poster Presentations at AHA Scientific Sessions 2024
Nov 18 RGNX REGENXBIO INITIATES PIVOTAL PHASE OF AFFINITY DUCHENNE® TRIAL OF RGX-202 GENE THERAPY AND REPORTS POSITIVE FUNCTIONAL DATA
Nov 18 RGNX FDA endorses speedy approval path for Regenxbio Duchenne gene therapy
Nov 15 RGNX Regenxbio down 13% ahead of data readout for muscular dystrophy asset
Nov 15 REGN FDA reviews Sanofi and Regeneron’s Dupixent label expansion for urticaria
Lipoprotein

A lipoprotein is a biochemical assembly whose primary function is to transport hydrophobic lipid (also known as fat) molecules in water, as in blood plasma or other extracellular fluids. They consist of a Triglyceride and Cholesterol center, surrounded by a phospholipid outer shell, with the hydrophilic portions oriented outward toward the surrounding water and lipophilic portions oriented inward toward the lipid center. A special kind of protein, called apolipoprotein, is embedded in the outer shell, both stabilising the complex and giving it a functional identity that determines its fate.
Many enzymes, transporters, structural proteins, antigens, adhesins, and toxins are lipoproteins. Examples include plasma lipoprotein particles (HDL, LDL, IDL, VLDL and chylomicrons). Subgroups of these plasma particles are primary drivers or modulators of atherosclerosis.

Browse All Tags